Oxford BioDynamics welcomes Dr Claudio Carini to its Scientific Advisory Panel
February 13, 2017Oxford BioDynamics, a producer of epigenetic biomarkers, has appointed Dr Claudio Carini as an Advisor to the company.
According to the press release, Dr Carini will be part of the Oxford Biodynamics scientific Advisory Panel.
The company welcomed Claudio, who has over 20 years’ experience in immunology, drug development, personalised medicine, and biomarkers. Previously, he was Global Head of Clinical Immunology & Biomarkers at Pfizer.
